New Unified AI ROI Dashboard bridges the gap between AI usage and financial accountability, providing a centralized view of risk, cost, and adoption.

MOUNTAIN VIEW, Calif., Sept. 15, 2026 — WitnessAI, the AI-native security platform trusted by leading enterprises, today announced the launch of new AI FinOps capabilities within the WitnessAI platform. The latest functionality, anchored with the addition of a Unified AI ROI Dashboard, is designed to help enterprises better understand and control AI spend across employees, models, and agents, and provide measurable data to showcase AI return on investment (ROI).

Enterprise AI adoption has created a new financial-management problem. As AI scales across multiple providers and applications, traditional invoices fail to show who is consuming AI, why, and whether it drives business value. According to WitnessAI’s The Hidden Cost of Enterprise AI report, only 9% of respondents stated that more than three-quarters of their AI initiatives have delivered a measurable financial return, while 33% said AI projects in the last 12 months were always or mostly over budget.

WitnessAI addresses the AI FinOps visibility challenge by operating at the AI traffic and intent layer. The platform connects spend directly to the intent behind the usage, tracking the specific employee, agent, purpose, activity, and model. This contextual visibility enables WitnessAI to combine capabilities that are typically separate, such as multi-provider metering, intelligent model routing, shadow AI discovery, and runtime security. This provides organizations with a single, unified view across three critical lenses: AI risk, cost, and adoption outcomes.

With this release, the WitnessAI platform adds:

• A customizable Unified AI ROI Dashboard: Centralizes AI performance metrics—including risk avoidance, cost savings, and adoption rates—into one dashboard across employees, models, and agents. Organizations can apply configurable ROI multipliers to assign custom dollar values to security incidents prevented, and employee time saved, ensuring the platform reflects an organization’s unique business economics.
• Comprehensive spend visibility and shadow AI discovery: Eliminates enterprise blind spots by automatically discovering unsanctioned AI applications, agents, and MCP servers. The platform accurately estimates shadow AI expenditures while metering sanctioned token consumption across multiple providers, mapping all usage directly to specific teams and business purposes.
• Intelligent routing and pre-inference optimization: Reduces inference costs without sacrificing quality. The platform scores prompts for complexity and business intent, routing tasks to the most cost-effective model. Additionally, pre-inference filtering automatically blocks non-business, off-topic, or abusive prompts before they incur paid token costs.

“With the launch of our new FinOps capabilities, we are changing how organizations think about AI ROI measurement. Instead of treating cost, risk, and adoption as siloed problems, WitnessAI gives leadership a consolidated view of AI economics,” said Rick Caccia, CEO and Founder of WitnessAI. “By translating security events and governance into tangible business terms, we are helping enterprises intelligently route workloads, eliminate shadow AI spend, and reduce waste without restricting the productive AI usage that drives their business forward.”

WitnessAI’s FinOps capabilities are now generally available to all customers. To learn more about the latest features, visit: https://witness.ai/witnessai-for-finops/ 

About WitnessAI 

WitnessAI is the AI security platform enterprises trust to govern and protect all AI activity. We provide complete visibility into every interaction including employees and autonomous agents, even in native apps where legacy tools are blind. Unlike traditional security that relies on outdated keywords, our AI-native platform understands intent, context, and meaning enabling intelligent policies that stop novel threats like prompt injection while empowering productivity. Our enterprise-first, single-tenant architecture ensures data sovereignty and compliance. WitnessAI transforms security from a bottleneck into the enabler of your AI strategy as the confidence layer for enterprise AI.

Media Contact
Katelyn Doherty
[email protected]

SOURCE WitnessAI

Chik brings nearly three decades of enterprise identity leadership and public company board experience to NewCore as enterprises race to secure a workforce of humans and AI agents

TEL AVIV, Israel and SAN FRANCISCO , Sept. 15, 2026 — NewCore, the next-gen IdP for humans and agents, today announced the appointment of Joy Chik to its Board of Directors. Chik brings 28 years of leadership experience, including her most recent role as President of the Identity and Network Access Business at Microsoft. She also serves on the Board of Directors of PayPal Holdings, Inc.

With this appointment, NewCore adds one of the enterprise identity industry’s most recognized executives to its board as the company scales its platform for a workforce of humans, machines, and AI agents.

Chik spent her career at the center of enterprise identity, from the rise of cloud and hybrid environments to the emergence of AI-driven enterprise operations. Over that period, she built and scaled identity infrastructure relied on by hundreds of thousands of organizations worldwide. Since announcing her departure from Microsoft in April 2026, she has focused on public company board service and on partnering with founders and leadership teams as they scale. Her deep technical background and track record of scaling identity programs at global enterprise scale make her a natural fit for NewCore’s mission.

“Joy has spent her career solving the hardest problems in enterprise identity, and she has done it at a scale that very few people in this industry have seen from the inside,” said Zohar Alon, co-founder and CEO of NewCore. “Joy understands identity security and the agentic impact as well as anyone in the industry, and her perspective will sharpen how we build, go to market, and help customers identify, secure, and govern human and agentic identities.”

“Enterprises are entering a new era in which people and AI agents will increasingly work side by side,” said Chik. “To operate securely at scale, organizations need clear ownership for every agent, appropriate access tied to a defined purpose, strong governance, and the ability to maintain accountability as these systems act with greater autonomy. The companies that put those foundations in place now will be best positioned to capture the value of the agentic workforce. I’ve chosen to spend this next chapter working with new startups as they address the challenges facing today’s world, and NewCore is taking a fundamentally new approach to one of the biggest. I’m excited to join the board at a time when the company is helping define what secure identity looks like in the agentic era.”

NewCore emerged from stealth in June 2026 with $66 million in funding from Cyberstarts, Index Ventures, and Evolution Equity Partners. Security innovation is the foundation of NewCore’s approach. Founded by cybersecurity veterans, NewCore rebuilt the identity platform from first principles to reduce risk, eliminate whole classes of identity attacks, and apply defense-grade engineering to every layer of the identity stack. The result is an IdP designed for today’s threat landscape, with strong security and governance for a workforce of humans and agents.

About NewCore

NewCore is the next-gen IdP for humans and agents. Rebuilt from the ground up, it secures, enables, and governs every human and agentic identity under a single, scalable architecture. Founded by cybersecurity veterans and Unit 8200 alumni. Backed by Cyberstarts, Index Ventures, and Evolution Equity Partners. Identity Secured.™

Learn more at newcore.com.

Media Contact

[email protected]

SOURCE NewCore

National Cancer Institute award focuses on the next phase of clinical and product development for Voro

DURHAM, N.C., Sept. 15, 2026 — Levee Medical, a medical device company focused on improving outcomes for men undergoing prostate cancer surgery, today announced that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

The two-year grant (Grant No. 1R44CA314945-01), effective August 1, 2026, provides approximately $2 million in non-dilutive funding. Selected through NCI’s competitive peer-review process, the project was evaluated for scientific and technical merit, along with its potential impact.

Funding will be used for clinical data collection, investigator training, design control activities and other initiatives supporting continued development of the Voro Urologic Scaffold. The announcement follows the completion of patient enrollment in ARID II, Levee Medical’s multicenter, randomized pivotal trial evaluating the safety and effectiveness of Voro in men undergoing robotic-assisted radical prostatectomy.

“Levee Medical has approached the development and clinical evaluation of the Voro with care and discipline, both in its management of the trial and its engagement with participating investigators,” said Mohummad Minhaj Siddiqui, MD, FACS, Professor and Chief of Urology at the University of Maryland School of Medicine. “This grant creates an opportunity to deepen the evaluation of a novel device and build on the progress already underway. I am encouraged by the company’s thoughtful and responsible approach to the program.”

“We are deeply grateful to NCI and NIH for their support and for the collaborative role federal agencies play in helping promising medical technologies move forward,” said Bruce Choi, Founder and CTO of Levee Medical. “Urinary incontinence after prostatectomy can profoundly affect a man’s quality of life, and there remains significant opportunity to improve recovery outcomes for these patients. This award allows us to broaden our clinical partnerships and continue developing Voro for the men and families affected by this complication.”

The NIH SBIR program helps U.S. small businesses pursue research and development with the potential for commercialization and public benefit. This funding complements Levee Medical’s ongoing PMA program and overall development strategy for the Voro Urologic Scaffold.

About Levee Medical

Levee Medical is dedicated to advancing solutions that aim to reduce complications associated with surgical treatment for prostate cancer. The Voro Urologic Scaffold is the first product Levee Medical plans to bring to market. This device is limited to investigational use and is not approved for commercial use in the United States or any other country.

For more information, visit www.leveemedical.com.

SOURCE Levee Medical

Verlinvest’s investment supports HomeExchange as it turns trust-based travel into a global movement.

NEW YORK, Sept. 15, 2026 — HomeExchange, the world’s largest home swapping platform, has secured a major investment from Verlinvest to accelerate its plan to make home exchanging a mainstream travel solution. The company has built the leading position in a category it pioneered over three decades ago, connecting members in 155 countries through a trust-based, non-monetary exchange model.

With its investment in HomeExchange, Verlinvest, a global, family-backed, consumer-focused evergreen investment firm, makes a meaningful addition to its portfolio of global, fast-growing companies. Verlinvest’s portfolio includes Oatly, Vita Coco, and Tony’s Chocolonely, with alumni including Chewy and Vitaminwater. The investment will support HomeExchange as it scales its global platform and deepens its presence in existing markets, with a particular focus on North America and Western Europe.

Ternel (Capital Croissance), a shareholder and impact investor since 2015 , is renewing its commitment alongside the founders to support this new phase of growth. ISAI, a shareholder since 2021 that supported HomeExchange through its latest growth phase, is exiting its stake as the company enters this new chapter. Co-Founders and co-CEOs Emmanuel Arnaud and Charles-Édouard Girard remain at the helm, both increasing their stake as part of the transaction.

Three decades of disrupting how the world travels
For over 30 years, HomeExchange has connected travelers around the world, exchanging homes instead of money, and rediscovering hospitality in its truest form. In the last year alone, the platform has enabled 2.3 million travelers to complete more than 11.8 million overnight stays. These numbers underscore the scale of the shift toward home exchanging as a mainstream form of travel. 

Emmanuel Arnaud, co-CEO of HomeExchange, said: “Home exchanging has moved from a niche idea to a proven way to travel, and HomeExchange has led that movement from the very beginning. This investment lets us grow it even further. Americans have shown that they’re ready to embrace new consumption models built on sharing rather than ownership. Verlinvest’s support gives us the resources and opportunity to accelerate our growth in the US and in Western Europe, allowing us to bring that experience to even more travelers while staying true to what has made HomeExchange successful.“

A long-term conviction in consumer shifts

Verlinvest was drawn to HomeExchange’s rare combination of scale and loyalty. The firm’s decision to invest reflects its confidence that HomeExchange’s community-first model can expand significantly further without compromising what has made it work.

Raphaël Thiolon, Managing Director at Verlinvest, said: “HomeExchange combines everything we look for at Verlinvest: a unique and innovative product, exceptional loyalty, a market still in its early stages with immense long-term growth potential, and, finally, a remarkable team that shares our ambition to create an iconic global brand. We believe HomeExchange can become one of the major ways people travel and experience hospitality, and we are proud to support Emmanuel and Charles-Edouard as they make that ambition a reality“.

Building a global home exchanging movement

HomeExchange’s ambition for this next chapter is clear: to make home exchanging a mainstream way to travel globally. To get there, the company is focused on three fronts:

• A richer, more seamless experience for every kind of traveler. HomeExchange keeps refining the platform, including a new messaging system and calendar, and is rolling out new filters, like the ability to see at a glance whether a cleaning service is offered.
• Standout offerings that set HomeExchange apart. HomeExchange continues to expand HomeExchange Collection, its curated tier of exceptional homes, alongside new features built for pet owners.
• A larger, more connected community. HomeExchange is growing a member base that already spans 155 countries, with the ambition to strengthen its lead in the markets where it’s already the leader. The United States and Western Europe are the company’s primary growth focus, supported by a dedicated team and local partnerships.

“We have been supporting HomeExchange since 2015, and today we are reinvesting with even greater conviction. This new chapter alongside Verlinvest illustrates our thesis as impact investors: to provide long-term support for business models that combine strong growth with real societal benefits,” emphasizes Mohamed Abdesslam, Managing Partner at Ternel.

“When we invested in 2021, we were convinced that HomeExchange was laying the foundations for a new category of travel. Five years later, that intuition has come to fruition. We are proud to have supported this team throughout this journey,” added Aude Lapillonne, Partner; Pierre Martini, Managing Partner; and Christophe Poupinel, General Partner, ISAI Expansion.

Media contacts
HomeExchange
Jessica Poillucci | [email protected]
Sarah Winston | [email protected] | 413-770-1790 

Verlinvest
[email protected]

About HomeExchange
HomeExchange is the world’s leading home swapping platform. Traveling with HomeExchange means staying in real homes without any financial transaction, based on the principle of reciprocity: each member lends out their home and, in return, is welcomed into another member’s home. Built on a community driven by trust and sharing, the platform enables millions of people to exchange homes each year and lists more than 600,000 homes in 155 countries.

Founded in 1992, HomeExchange was acquired in 2017 by Emmanuel Arnaud and Charles-Édouard Girard, co-founders of GuestToGuest (2011), the platform behind the GuestPoints system, which allows users to exchange homes with greater flexibility, without having to coordinate the availability of two households at the same time.

After acquiring several home exchange platforms between 2013 and 2023—all consolidated under the HomeExchange brand in 2019 — the company launched HomeExchange Collection in 2021, a service dedicated to exceptional homes. A certified B Corp™ since 2022, the company employs over 150 people across France, Croatia, Spain, and the United States.

www.homeexchange.com 

About Verlinvest
Verlinvest is an international, family-backed evergreen investment company. Verlinvest identifies inflection points in consumer behaviors and partners with the businesses driving these consumer revolutions forward while having a positive impact. Established in 1995, with offices in Brussels, London, New York, Singapore, and Mumbai, Verlinvest focuses on the FMCG, health, consumer technology and lifestyle categories, investing across three strategies: Venture, Growth, and Platform — from early-stage backing through large-scale brand building.

The company has over €2.5bn in AuM and counts brands such as Oatly, Vita Coco, Tony’s Chocolonely, Purplle, K1 Speed, Mutti, Who Gives A Crap, and Insomnia Cookies among its portfolio, alongside alumni Chewy, Sula, and Vitaminwater.

Further information is available at www.verlinvest.com

SOURCE HomeExchange

New Decision Intelligence platform examines patterns across conversations and profiles to help people evaluate what the evidence actually supports before deciding what to do next

GEORGETOWN, Ky., Sept. 15, 2026 — Someone responds warmly to a message but never answers the invitation to meet. The conversation continues. Later, another attempt to make plans gets a response, but again, not an answer.

Each message may look perfectly normal on its own. The pattern across them may tell a different story.

That’s the kind of distinction Perscivo was built to examine.

Perscivo is a new Decision Intelligence platform for modern relationships. Users provide conversation text, screenshots or profile information they already possess. The platform analyzes evidence across an interaction and produces a structured Decision Brief identifying patterns, supporting observations, uncertainty, confidence and risk.

“Dating apps have created incredible opportunities for people to meet,” said George Mangos, Founder & CEO of Perscivo. “But once you connect, you still have to figure out what the interaction actually means. Someone responding isn’t necessarily the same as someone answering. Someone being friendly isn’t necessarily the same as a relationship progressing. Perscivo helps you look at the evidence before deciding what to do next.”

That decision is taking place inside a substantial digital economy. Grand View Research estimates the global online dating market at approximately $13 billion in 2026, with subscriptions representing its largest revenue segment. At the same time, major dating platforms maintain dedicated systems to combat fake, spam and otherwise inauthentic accounts, while the Federal Trade Commission reported $1.14 billion in consumer losses from romance scams in 2023.

Perscivo does not attempt to determine whether another person is real or fake, authenticate identities or perform facial recognition. It also does not scrape or require integration with dating platforms.

Instead, it applies structured analysis to the information a user already has. A Decision Brief can identify evidence involving communication, reciprocity, momentum and investment, distinguish observations from assumptions, and explicitly acknowledge when there isn’t enough evidence to reach a confident conclusion.

“We’re not trying to replace dating apps or human judgment,” Mangos said. “We’re trying to give the person making the decision a little more information and a more level playing field before they invest more time, attention, emotion or money.”

Perscivo is available on the web for $14.99 per month following a three-day trial, plus applicable taxes.

Journalists interested in evaluating Perscivo can request product access, review anonymized Decision Briefs, or test the platform using their own sample conversations.

About Perscivo

Perscivo is a Decision Intelligence platform for modern relationships designed to help people distinguish evidence from assumptions, recognize meaningful patterns and uncertainty, and make better-informed decisions about their connections.

Media Contact
George Mangos
Founder & CEO, Perscivo
859-469-3204
[email protected] 
https://perscivo.com/

SOURCE Perscivo LLC

PRINEVILLE, Ore., Sept. 15, 2026 — Samson Sky, makers of the Switchblade Flying Car announced they have secured an investment of $80 million from Dubai-based Matin Group. According to Sam Bousfield, CEO and Founder of Samson Sky and designer of the Switchblade, these funds will be used to establish Samson Sky’s first 180,000 square foot Switchblade production facility, to be located in the U.S.

Samson Sky announced they have signed a Joint Investment Agreement with the Matin Group, and the two companies have begun setting up the Joint Venture to accelerate into commercial production, with $20M still remaining to be raised for full production funding.

The transaction reflects Matin Group’s strategy of selectively partnering with innovative, execution-ready businesses that combine strong commercial potential with long-term value creation. Former aerobatic pilot and Samson Sky Ambassador Anna V. Grebenshchikova was instrumental in bringing the two organizations together.

“At the start, Mr. Matin saw the Switchblade’s relevance, and its ability to make a difference in the world, and our two companies quickly advanced to a position of trust,” said Bousfield. “We are proud to have such a forward-thinking partner as we roll the Switchblade out to the world.”

“The future is not built by those who wait for certainty—it is built by those who recognize possibility before it becomes obvious. At Matin Group, we partner with people who have the courage to challenge convention and the discipline to deliver. Samson Sky is one of those rare companies, and we are proud to support their journey as they redefine the future of mobility, because we believe the most meaningful investments are those that create lasting value—not only for shareholders, but for society as a whole,” stated Mustafa Matin, CEO of Matin Group.

With seating for two plus luggage, the Switchblade Flying Car is a hybrid-electric driving and flying vehicle with sports car performance on the ground and high performance in the air. It runs on premium auto gas, fits in a standard garage and is driven to a nearby airport using highways or local roads.

Matin Group is a privately held, family-led investment and strategic holding group headquartered in Dubai, United Arab Emirates, with origins in London. Through its Finance and  Investment division, the Group specializes in structured project financing, investment structuring, and selective equity participation, partnering with experienced operators, institutions, and project sponsors across multiple sectors.

Guided by disciplined capital allocation and long-term value creation, Matin Group invests in opportunities where strategic partnership, sound governance, and execution excellence create enduring commercial value. The Group maintains an international outlook with activities spanning the Middle East, Europe, Central Asia, Africa, and North America. 

Samson Motors, Inc. (dba Samson Sky) has been dedicated in designing, building, and testing the industry-leading Switchblade Flying Car as a high-performance vehicle that both drives and flies, to solve the problems of Regional Travel (200-500 miles). For safety and insurability, all flying surfaces are enclosed within the vehicle while in driving mode. The Switchblade transforms from driving to flying mode in three minutes at the push of a button. The Switchblade Flying Car had its successful official First Flight in Nov. 2023. Samson Sky is now bringing that world-class vehicle into production to satisfy the demand from 50 countries world-wide and from each of the 50 States in the U.S.  

For more information about the Switchblade and to follow its progress into production, visit: www.SamsonSky.com

Media Contact:

Gail Gallegos 916-769-6979 (Mobile)
[email protected] 
Additional Hi-Res images available by request

PLEASE NOTE:
The Switchblade is an Experimental category aircraft. The U.S. Federal Aviation Administration (FAA) does not provide Certification for this category of aircraft – they certify aircraft that are fully produced in a factory by the manufacturer.

With all Experimental aircraft, the FAA designates that the owner must build 51% of the vehicle. All Switchblade owners will spend one week at the Samson Builder Assist Center, building 51% of their Switchblade. Following this, Samson will complete their vehicle.

SOURCE Samson Sky

Therna’s novel proprietary method generates millions of functional RNA measurements within a dynamic biological system, producing unique data sets from single experiments. A representative data set is now available to researchers and prospective partners.

SAN FRANCISCO, Sept. 15, 2026 — Therna Biosciences, a biotechnology company whose AI RNA Biologist, RNA-Logix™, translates RNA language into medicines, today announced the launch of Chronos and the public release of one representative Chronos study set. Chronos is the novel data engine of RNA-Logix™, generating orders of magnitude more functional RNA data than the industry standard in a single experiment, representing the complexity of a whole biological system.

Chronos is a highly multiplexed measurement of expression dynamics for tens of thousands of synthetic genes and mRNAs across dozens of diverse human cell lines, resulting in millions of functional RNA measurements in every single experiment. Researchers and prospective partners can use the released study sets to train and benchmark sequence-to-function models, test how the same RNA sequence behaves across different cellular contexts and over time, and evaluate design rules for expression, stability, and cell-type-specific behavior.

“All biological models, including RNA design models, are defined by the quality and scale of the biological data behind their design and whether it represents the complexity of the biological system,” said Nazli Azimi, Ph.D., Chief Executive Officer of Therna. “Therna is built on the belief that RNA is a language, and that a company able to understand it can write medicines in it. RNA-Logix™ is Therna’s AI RNA Biologist, unlocking new biology and designing the novel medicines that act on it. All of that begins with data. Chronos fundamentally changed how we generate that data at a scale and the complexity that interrogates RNA dynamics within a living system. We are releasing one data set to show the field what becomes reachable when scale and dynamic measurements are taken into account.”

Conventional methods measure one mRNA, in one cell type, at one moment. Chronos measures tens of thousands of synthetic mRNAs across a pool of 50 human cell lines and follows them over time, all within a single experiment, at a scale that would otherwise take months of separate experiments to assemble. Analyzing millions of single cells requires a matching computational approach. Therna achieved an approximately 200x speedup using rapids-single cell, an open-source scverse package built on NVIDIA CUDA-X for Data Science.

“For years we could ask what one RNA does in one cell type and get a clean answer to a narrow question. Chronos lets us ask what thousands of sequences do across 50 cellular contexts at once, and the answer is not the same in every cell,” said Hani Goodarzi, Ph.D., Scientific Co-Founder of Therna, Core Investigator at the Arc Institute, and faculty at the University of California, San Francisco. “That variation is the point. It tells us how a sequence and the cell reading it combine to set behavior, which is what a model of the cell needs to learn and has not had. It also turns that biology into design: which part of an RNA to target to drive a therapeutic response, and what to put into an mRNA so it works hardest in the cell type we are aiming at.”

Therna is releasing the Chronos data set conducted on 50 human cell lines (courtesy of Tahoe Therapeutics). The release comprises one study set generated on Chronos: Penta-47x27K and Tria-47x28K which are available on Hugging Face, along with a technical white paper covering the data set, quality control, and preliminary sequence-to-function modeling. In collaboration with Lightning AI, Therna is also releasing a Lightning Studio so users can interact with the data directly. The release does not include experimental protocols or Therna’s RNA foundation models. A separate Chronos study set generated in human immune cells remains proprietary, supporting the Company’s internal programs and partnered work.

Therna is making these study sets available so prospective partners and the broader community can see the scale and complexity of the data that RNA-Logix™ is built and trained on. The Company invites researchers to train on the study sets, benchmark against them, and publish their findings, and welcomes contact from organizations that see an application to their own biology.

Organizations interested in applying Therna’s proprietary human immune cell Chronos study set to their own biology are invited to contact Therna about collaboration.

About Therna Biosciences

Therna is a biotechnology company translating RNA language into medicines. Its platform, RNA-Logix™, is an AI RNA Biologist that unlocks new biology and designs the novel medicines that act on it. Because RNA-Logix™ treats mRNA both as a medicine and as a target, Therna designs across modalities on one platform, engineering mRNA optimized for translation, stability, immune evasion, and tissue-specific expression, and identifying optimal target sites within mRNA for ASO and siRNA design. Therna’s technology can increase, decrease, or finely tune gene expression, enabling applications across cardiovascular, metabolic, immunological, and genetic diseases, in addition to ultra-rare, individualized treatments. Headquartered in San Francisco, Therna is backed by leading investors and scientific advisors at the forefront of RNA and AI innovation. Please visit therna.com for more information.

SOURCE Therna Biosciences

Investment will accelerate Radian Forge’s advanced manufacturing capacity for U.S. naval, maritime and defense applications.

MCLEAN, Va., Sept. 15, 2026 — Veteran Ventures Capital (VVC) today announced that it has led the $2.5 million Series Seed Preferred financing in Radian Forge, a Virginia-based advanced manufacturing company building on-demand production capacity for the U.S. maritime and defense industrial base.

The financing was made through VVC’s Fund II, with additional participation from the Virginia Innovation Partnership Corporation (VIPC) and Radian Forge’s existing investors.

Headquartered in Portsmouth, Virginia, adjacent to some of the nation’s largest naval shipbuilding and repair facilities, Radian Forge produces large-scale, precision-grade metal components for naval, maritime and defense applications using large-format Wire Arc Additive Manufacturing (WAAM). The process produces large, complex components with material properties between castings and forgings, while reducing production lead times by 40–80% and enabling each WAAM robot to operate with a single operator.

“The United States cannot sustain naval power or rebuild its fleets without a responsive manufacturing base capable of producing critical components at the speed of the mission,” said Joshua Weed, General Partner at Veteran Ventures Capital, who led the investment and will join Radian Forge’s Board of Directors. “Radian Forge is building the domestic manufacturing capacity needed to help close that gap.”

The investment comes as the United States works to rapidly expand shipbuilding and repair capacity, strengthen domestic supply chains and address production constraints across the maritime industrial base.

“America has spent decades accepting manufacturing timelines that no longer match the urgency of the mission. We don’t accept them. Radian Forge is building the capacity to put critical components into the hands of our customers in weeks, not months. This investment allows us to move faster and scale that capability. Veteran Ventures understands that this isn’t just a manufacturing problem—it’s a readiness problem—and that’s exactly the kind of partner we want beside us,” said Jeff Yeager, CEO of Radian Forge and former U.S. Marine.

In February 2026, Governor Abigail Spanberger announced that Radian Forge would invest $10.5 million to expand its Portsmouth operations, creating 53 new jobs, with the Commonwealth approving a $265,000 Opportunity Fund grant. VIPC’s latest direct equity investment expands and strengthens the Commonwealth’s commitment.

About Veteran Ventures Capital

Veteran Ventures Capital invests in dual-use national security technologies, focusing on companies led by veteran entrepreneurs and operators. Committed to advancing U.S. technological superiority, Veteran Ventures Capital provides capital, mentorship, and strategic guidance to high-growth companies serving critical government and commercial markets. VVC’s portfolio includes leading companies in defense, aerospace, advanced manufacturing, cybersecurity, and other sectors essential to national security, including notable investments in Vatn Systems, Hidden Level, Cambium, Agile Space Industries, Turion Space, Hybron Technologies, and Asylon Robotics, amongst others. For more information, visit www.veteranventures.us and follow the firm on LinkedIn.

About Radian Forge

Radian Forge restores speed, scale, and resilience to U.S. defense manufacturing. The company produces large-scale, precision-grade metal components for naval, maritime, and defense applications using large-format Wire Arc Additive Manufacturing, enabling faster production, reduced lead times, and a stronger maritime industrial base. Founded and led by Jeff Yeager, a service-disabled U.S. Marine Corps veteran, Radian Forge is built by those who understand the mission and the manufacturing systems that support it. For more information, visit radianforge.com.

Media Contact

For media inquiries, please contact: [email protected]

SOURCE Veteran Ventures Capital

Open-1b lets anyone independently verify how it was trained, setting a new standard for transparency and accountability for future AI systems.

LONDON, Sept. 15, 2026 — Gensyn, the industry’s leading decentralized AI lab, announced the launch of open-1b, a verifiable AI model designed to allow anyone to test and independently verify how it was trained.

As AI plays a growing role in human life, influencing personal and business decisions, transparency into its development remains closed off. Users have little insight into how these systems are built, trained, or shaped by data. Meanwhile, leaders from the world’s largest AI companies continue to warn about the risks of the technology’s rapid advancement.

Ben Fielding, Co-Founder and CEO of Gensyn, explained, “Auditable AI means a model’s decisions do not have to come from a black box like Anthropic or OpenAI models. Today, Gensyn has unveiled the toolkit that allows someone to inspect the data that shaped it, verify the training process step by step, and understand why it reached a particular conclusion. To achieve our goals with Gensyn, we need AI models that anyone can trust and verify themselves without relying on a company’s version of the truth. Open-1b is a tremendous milestone for the AI industry, proving a path toward verifiable AI, an absolute necessity for the future of intelligence.”

How open-1b compares to existing AI models:

• Closed AI models (e.g., Claude, ChatGPT): Provide access to model outputs, while keeping training methodologies entirely proprietary.
• Open-weight models (e.g., Llama): Distribute model weights, but omit the underlying training process.
• Open-recipe models (e.g., OLMo): Offer both the model weights and the instructions used for training.
• Auditable AI (Gensyn’s open-1b): Delivers the model, the training recipe, and verifiable proof allowing third parties to independently audit any stage of training.

Simply sharing an AI model’s code and datasets is insufficient for true independent verification, as hardware variations frequently lead to inconsistent results. Gensyn addresses this fundamental challenge by providing infrastructure that ensures training outcomes can be accurately reproduced and verified across diverse hardware. Demonstrating this capability, open-1b lays the groundwork for fully auditable artificial intelligence.

Gensyn is moving AI transparency beyond disclosure to proof, giving people the tools to verify how a model was trained for themselves.

About Gensyn
Gensyn is a decentralized AI lab building forecasting systems that continuously improve by learning from real-world outcomes. Its technology combines verifiable AI infrastructure, which allows predictions to be checked against independently verified outcomes, with incentives for people to contribute new information that models have not previously seen. Together, these capabilities create a continuous cycle of prediction, verification, and learning.

Gensyn is backed by a16z crypto, CoinFund, Galaxy Digital, Eden Block, Maven 11, and more. For more information, visit gensyn.ai.

Media Contact
Michelle O’Connor
‪(415) 578-0156
[email protected]

SOURCE Gensyn